DEVELOPMENT OF NOVEL COUNTERMEASURES FOR RESPIRATORY DISEASES

开发呼吸系统疾病新对策

• 批准号: 8654940
• 负责人: Anne Kathleen Radcliff
• 金额: $ 322.74万
• 依托单位: CUBRC, INC.
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-27 至 2015-07-03
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8654940
• 关键词: Advanced Development; Anti-Bacterial Agents; Antimicrobial Resistance; Clinical; Development; Drug resistance; Lung diseases; Respiratory Tract Infections; Support Contracts; Therapeutic; Translational Research; Yersinia pestis; biodefense; novel; pathogen; pre-clinical; product development; research and development

This contract supports the advanced development of promising biodefense therapeutic candidates/products with broad spectrum activity. The research and development activities supported will allow candidate therapeutic countermeasures to progress through the product development pipeline, and includes preclinical/non-clinical and clinical IND development activities.

该合同支持具有广谱活性的有前途的生物防御治疗候选物/产品的先进开发。支持的研发活动将允许候选治疗对策通过产品开发管道取得进展，包括临床前/非临床和临床IND开发活动。